Hidemaru Yamaguchi
Stock Analyst at Citi
(1.70)
# 3,495
Out of 4,670 analysts
65
Total ratings
51.2%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Hidemaru Yamaguchi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4503 Astellas Pharma Inc. | Maintained: Hold | ¥2,400 → ¥2,470 | ¥2,387 | +3.48% | 4 | Aug 7, 2026 | |
| TYO: 4587 PeptiDream Inc. | Maintained: Hold | ¥1,600 → ¥1,100 | ¥1,115 | -1.30% | 3 | Jul 22, 2026 | |
| TYO: 4592 SanBio Company Limited | Upgraded: Buy | ¥1,800 | ¥1,010 | +78.22% | 1 | Jul 16, 2026 | |
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Maintained: Sell | ¥1,260 → ¥1,500 | ¥1,412 | +6.27% | 5 | May 25, 2026 | |
| TYO: 2503 Kirin Holdings Company, Limited | Downgraded: Hold | ¥2,800 | ¥3,038 | -7.83% | 1 | Apr 3, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥3,800 → ¥2,000 | ¥2,577 | -22.38% | 2 | Mar 10, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Buy | ¥2,600 → ¥2,800 | ¥1,708 | +63.93% | 6 | Feb 9, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥5,800 → ¥4,900 | ¥2,834 | +72.93% | 6 | Feb 5, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Maintained: Hold | ¥600 → ¥670 | ¥529 | +26.65% | 4 | Feb 5, 2026 | |
| TYO: 4565 Nxera Pharma Co., Ltd. | Maintained: Buy | ¥1,100 → ¥1,400 | ¥1,103 | +26.93% | 5 | Nov 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥5,900 → ¥6,200 | ¥4,902 | +26.48% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,800 → ¥3,900 | ¥2,569 | +51.81% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,200 → ¥3,500 | ¥4,043 | -13.43% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥1,750 | ¥2,448 | -28.51% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥10,400 → ¥10,500 | ¥12,195 | -13.90% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥5,100 → ¥4,600 | ¥3,667 | +25.44% | 3 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,600 | ¥1,880 | n/a | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥4,200 → ¥3,500 | ¥3,895 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,410 | ¥2,918 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥960 | ¥1,473 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥2,600 | ¥2,170 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥12,000 | ¥7,011 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,100 → ¥2,800 | ¥2,919 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,300 | ¥1,977 | n/a | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $32.82 | n/a | 1 | Mar 29, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $25.05 | n/a | 1 | Nov 18, 2009 |
Astellas Pharma Inc.
Aug 7, 2026
Maintained: Hold
Price Target: ¥2,400 → ¥2,470
Current: ¥2,387
Upside: +3.48%
PeptiDream Inc.
Jul 22, 2026
Maintained: Hold
Price Target: ¥1,600 → ¥1,100
Current: ¥1,115
Upside: -1.30%
SanBio Company Limited
Jul 16, 2026
Upgraded: Buy
Price Target: ¥1,800
Current: ¥1,010
Upside: +78.22%
Sumitomo Pharma Co., Ltd.
May 25, 2026
Maintained: Sell
Price Target: ¥1,260 → ¥1,500
Current: ¥1,412
Upside: +6.27%
Kirin Holdings Company, Limited
Apr 3, 2026
Downgraded: Hold
Price Target: ¥2,800
Current: ¥3,038
Upside: -7.83%
Kyowa Kirin Co., Ltd.
Mar 10, 2026
Downgraded: Sell
Price Target: ¥3,800 → ¥2,000
Current: ¥2,577
Upside: -22.38%
M3, Inc.
Feb 9, 2026
Maintained: Buy
Price Target: ¥2,600 → ¥2,800
Current: ¥1,708
Upside: +63.93%
Daiichi Sankyo Company, Limited
Feb 5, 2026
Maintained: Buy
Price Target: ¥5,800 → ¥4,900
Current: ¥2,834
Upside: +72.93%
JCR Pharmaceuticals Co., Ltd.
Feb 5, 2026
Maintained: Hold
Price Target: ¥600 → ¥670
Current: ¥529
Upside: +26.65%
Nxera Pharma Co., Ltd.
Nov 28, 2025
Maintained: Buy
Price Target: ¥1,100 → ¥1,400
Current: ¥1,103
Upside: +26.93%
Sep 12, 2025
Maintained: Buy
Price Target: ¥5,900 → ¥6,200
Current: ¥4,902
Upside: +26.48%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,800 → ¥3,900
Current: ¥2,569
Upside: +51.81%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,200 → ¥3,500
Current: ¥4,043
Upside: -13.43%
Aug 28, 2025
Maintained: Hold
Price Target: ¥1,750
Current: ¥2,448
Upside: -28.51%
Aug 27, 2025
Maintained: Buy
Price Target: ¥10,400 → ¥10,500
Current: ¥12,195
Upside: -13.90%
Aug 26, 2025
Maintained: Buy
Price Target: ¥5,100 → ¥4,600
Current: ¥3,667
Upside: +25.44%
Aug 22, 2025
Maintained: Buy
Price Target: ¥2,600
Current: ¥1,880
Upside: n/a
Aug 22, 2025
Maintained: Buy
Price Target: ¥4,200 → ¥3,500
Current: ¥3,895
Upside: n/a
Jun 26, 2025
Maintained: Hold
Price Target: ¥2,410
Current: ¥2,918
Upside: n/a
Jun 26, 2025
Maintained: Hold
Price Target: ¥960
Current: ¥1,473
Upside: n/a
Jun 24, 2025
Downgraded: Hold
Price Target: ¥2,600
Current: ¥2,170
Upside: n/a
May 27, 2025
Maintained: Buy
Price Target: ¥12,000
Current: ¥7,011
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ¥3,100 → ¥2,800
Current: ¥2,919
Upside: n/a
Nov 26, 2024
Maintained: Hold
Price Target: ¥3,300
Current: ¥1,977
Upside: n/a
Mar 29, 2010
Upgraded: Buy
Price Target: n/a
Current: $32.82
Upside: n/a
Nov 18, 2009
Upgraded: Hold
Price Target: n/a
Current: $25.05
Upside: n/a